Is there an association between Helicobacter pylori infection and coronary heart disease?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Graham D, Malaty H, Evans D, et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Gastroenterology 1991; 100: 1495–1501.
Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: A review. Gastroenterology 1996; 110: 1244–1252.
Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132–1136.
Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127–1131.
Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. BMJ 1991; 302: 1302–1305.
Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267–1271.
Patel P, Mendall M, Northfield T. Manifestations extra-digestives associées à l'infection à Helicobacter pylori. In: Mégraud F, Lamouliatte H (eds), Helicobacter pylori, Vol 2. Paris: Elsevier, 1997: 309–316.
Murray C, Lopez A. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269–1276.
Heller RF, Miller NE, Wheeler MJ, et al. Coronary heart disease in ‘low risk’ men. Atherosclerosis 1983; 49: 187–193.
Heller RF, Chinn S, Pedoe HG, et al. How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. BMJ 1984; 288: 1409–1411.
Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction. Br Med J 1989; 298: 779–781.
Gupta S, Leatham E, Carrington D, et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivor of myocardial infarction. Circulation 1997; 96: 404–407.
Gurfinkel E, Bozovich G, Daroca A, et al. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet 1997; 350: 404–407.
Mendall M, Goggin M, Molineaux N, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71: 437–439.
Maier F, Auricchio A, Nilius M, et al. Lack of association between Helicobacter pylori infection and angiographically documented Coronary Heart Disease. Gut 1996; 39(Suppl 2): A92 (abstract).
Delaney BC, Hobbs FDR, Holder R. Association of Helicobacter pylori infection with coronary heart disease — Eradication of the infection on grounds of cardiovascular risk is not supported by current evidence. BMJ 1996; 312: 251–252.
Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: Is there a link? Lancet 1997; 350: 430–436.
Spitzer WO, Skovron ML, Salmi LR, et al. Scientific monograph of the Quebec Task Force on Whiplash-Associated Disorders: Redefining ‘whiplash’ and its management. Spine 1995; 20: 1S-73S.
Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17: 1–12.
Petitti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis: Methods for quantitative synthesis in medicine. New York: Oxford University Press, 1994.
Martin de Argila C, Boixeda D, Canton R, et al. High seroprevalence of Helicobacter pylori infection in Coronary Heart Disease. Lancet 1995; 346: 310.
Morgando A, Sanseverino P, Perotto C, et al. H. pylori seropositivity in myocardial infarction. Lancet 1995; 345: 1380.
Murray LJ, Bamford KB, Oreilly DPJ, et al. Helicobacter pylori infection: Relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J 1995; 74: 497–501.
Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J 1995; 311: 711–714.
Niemela S, Karttunen T, Korhonen T, et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 1996; 75: 573–575.
Whincup PH, Mendall MA, Perry IJ, et al. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart 1996; 75: 568–572.
Rathbone B, Martin D, Stephens J, et al. Helicobacter pylori seropositivity in subjects with acute myocardial infarction. Heart 1996; 76: 308–311.
Ponzetto A, Larovere MT, Sanseverino P, et al. Association of Helicobacter pylori infection with coronary heart disease — Study confirms previous findings. Br Med J 1996; 312: 251.
Aceti A, Mazzacurati G, Amendolea MA, et al. H. pylori and C.-pneumoniae infections may account for most acute coronary syndromes. Br Med J 1996; 313: 428–429.
Aromaa A, Knekt P, Reunanen A, et al. Helicobacter infection and the risk of myocardial infarction. Gut 1996; 39(Suppl 2): A91 (abstract).
Caselli M, Kubbajeh M, Ruina M, et al. Helicobacter pylori and heart. Gut 1996; 39(Suppl 2): A91 (abstract).
Martin de Argila C, Boixeda D, Fuertes A, et al. High prevalence of Helicobacter pylori infection in Coronary Heart Disease demonstrated by the 13C-Urea breath test. Gut 1996; 39(Suppl 2): A95 (abstract).
Rajput-Williams J, Williams NR, Johnson PG, et al. Fibrinogen and H. pylori in asymptomatic post MI patients and healthy controls. Gut 1996; 39(Suppl 2): A94 (abstract).
Treiber G, Schneider E, Adolph C, et al. Helicobacter pylori (HP), coronary heart disease (CHD) and plasma fibrinogen: Is there a causal link? Gut 1996; 39(Suppl 2): A29 (abstract).
Vakil N, Khurshid A, Fenske T, et al. H. pylori infection in patients with and without coronary artery disease. Gut 1996; 39(Suppl 2): A91 (abstract).
Maier F, Auricchio A, Nilius M, et al. Lack of association between H. pylori infection and angiographically documented coronary heart disease. Gastroenterology 1996; 110: 183 (abstract).
Neri M, Reale M, Febbo CD, et al. Increased levels of soluble tumour necrosis factor receptor I (sTNF RI) in serum of H. pylori positive IHD patients. Gastroenterology 1996; 110: 209 (abstract).
Khurshid A, Puetz T, Fenske T, et al. Sero-prevalence of H. pylori infection in patients with and without angiographic evidence of coronary heart disease. Gastroenterology 1996; 110: 154 (abstract).
Balaban DH, Peura DU, Watson D, et al. Relationship between H. pylori infection and ischemic heart disease. Gastroenterology 1996; 110: 55 (abstract).
Malnick S, Adlan K, Goland S, et al. High incidence of Helicobacter pylori seropositivity in young patients with coronary artery disease. Gut 1996; 39(Suppl 3): A63/378 (abstract).
McDonagh T, Woodward M, Morrison C, et al. Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur Heart J 1997; 18: 1257–1260.
Ossei Gerning N, Moayyedi P, Smith S, et al. Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovascular Research 1997; 35: 120–124.
Strandberg TE, Tilvis RS, Vuoristo M, et al. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ 1997; 314: 1317–1318.
Pasceri V, Patti G, Cammarota G, et al. Association of Cytotoxin-Associated Gene A Helicobacter pylori with Ischemic Heart Disease. Circulation 1997; 96: I-32 (abstract).
Quinn M, O'Connor F, Foley B, et al. Helicobacter pylori and coronary artery disease: Is there an association? Eur Heart J 1997; 18(Suppl): 217/P1257 (abstract).
Pearson Thomas A. Coronary arteriography in the study of the epidemiology of Coronary Artery Disease. Epidemiologic Reviews 1984; 6: 140–166.
Bradford Hill A. The environment and disease: Association or causation. Proc R Soc Med 1965; 58: 295–300.
Banatvala N, Mayo K, Megraud F, et al. The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168: 219–221.
Blasi F, Denti F, Erba M, et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996; 34: 2766–2769.